Cresemba Approval History
FDA Approved: Yes (First approved March 6, 2015)
Brand name: Cresemba
Generic name: isavuconazonium
Dosage form: Capsules and Injection
Company: Astellas Pharma US, Inc.
Treatment for: Invasive Aspergillosis; Invasive Mucormycosis
Cresemba (isavuconazonium) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis.
Development History and FDA Approval Process for Cresemba
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.